arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MILESTONE SCIENTIFIC INC.

MLSS
$0.30 ▼ -0.02 (-5.18%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
17 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
10
Health
Poor
Bearish
auto_awesome

Analytical Summary

MILESTONE SCIENTIFIC INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $24.6M
Dividend Yield —
Revenue Growth 4.0% ↗
Op. Margin -63.5% ↗
ROIC -160.0% ↘
FCF / Share $-0.04 ↗
Trailing P/E —
Price / Book 8.6x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.97M
↑ +4.0% —
Net Income Profit after all expenses
$-5.72M
↓ -21.4% —
Operating Margin Operating profit as % of sales
-63.5%
↑ +18.9% 4th
FCF / Share Free cash flow per share
$-0.04
↑ +2.7% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
5
Returns ↓
2
Cash Quality ↓
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 67 quarters